Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction | Zendy

Bernhard Witzenbichler | Zendy; Jochen Wöhrle | Zendy; Giulio Guagliumi | Zendy; Jan Z. Peruga | Zendy; Bruce R. Brodie | Zendy; Dariusz Dudek | Zendy; Ran Kornowski | Zendy; Franz Hartmann | Zendy; Kristin L. Hood | Zendy; Helen Parise | Zendy; Alexandra J. Lansky | Zendy; Eugenia Nikolsky | Zendy; Roxana Mehran | Zendy; Gregg W. Stone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction

Author(s) -

Bernhard Witzenbichler,

Jochen Wöhrle,

Giulio Guagliumi,

Jan Z. Peruga,

Bruce R. Brodie,

Dariusz Dudek,

Ran Kornowski,

Franz Hartmann,

Kristin L. Hood,

Helen Parise,

Alexandra J. Lansky,

Eugenia Nikolsky,

Roxana Mehran,

Gregg W. Stone

Publication year - 2011

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.110.960245

Subject(s) - medicine , hazard ratio , myocardial infarction , cardiology , percutaneous coronary intervention , diabetes mellitus , confidence interval , stent , revascularization , surgery , endocrinology

In the prospective, randomized Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, implantation of paclitaxel-eluting stents (PES) safely reduced the rates of ischemic target lesion revascularization (TLR) compared with bare metal stents (BMS) in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention. Diabetes mellitus is a known predictor of adverse outcomes after percutaneous intervention in STEMI. We therefore sought to assess the impact of PES in diabetic patients with STEMI from the HORIZONS-AMI trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research